Olanzapine use in five different psychiatric disorders in children and adolescents;Çocuk ve ergenlerde beş farkli psikiyatrik bozuklukta olanzapin kullanimi

Klinik Psikofarmakoloji Bulteni

Volumn 12, Issue 4, 2002, Pages 179-185

  Bozabali, Özlem Gencer ^a   Baykara, Burak ^a   Baykara, Ayşen ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Autistic disorder; Early onset schizophrenia; Eating disorder; Mood disorders; Olanzapine; Tourette's disorder

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE;

ADOLESCENT; ARTICLE; BODY WEIGHT DISORDER; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG INDICATION; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; MENTAL DISEASE; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0036980679     PISSN: 10177833     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Findling RL, Grcevich SJ, Lopez I, Schulz SC. Antipsychotic medication in children and adolescents. J Clin Psychiatry 1996;57 (suppl 9):19-23.
2. Toren P, Laor N, Weizmen A. Use of atypical neuroleptics in child and adolescent psychiatry. J Clin Psychiatry 1998;59:644-656.
3. Krishnamoorthy J, King BH. Open-label olanzapine treatment in five preadolescent. Children J Child Adolesc Psychopharmacol 1998;8:107-113.
4. Kumra S, Jocobsen LK, Lenane M, Karp BI, Frazier JA, Smith AK, Bedwell J, Lee P, Malanga CJ, Hamburger S, Rapoport JL. Childhood-onset schizophrenia: an open label study of olanzapine in adolescents. J Am Acad Child Adolesc Psychiatry 1998;37:377-385.
5. Ratzoni G, Gothelf D, Brand-Gothelf A, Reidman J, Kikinzon L, Gal G, Philip M, Apter A, Weizman R. Weight gain associated with olanzapine and risperidon in adolescent patients:a comperative prospective study. J Am Acad Child Adolesc Psychiatry 2002;41:337-343.
6. Melkerson K, Hulting AL, Brismar K. Elevated levels of insulin, leptin and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 2000;61:741-749.
7. Herran A, Unzueta M, Amado JA, LaMaza MT, Alvarez C, Barquero E. Effect of loong term treatment with antipsychotics on serum leptin levels. Br J Psychiatry 2001;179:59-62.
8. Mandoki M. Olanzapine in the treatment of early onset schizophrenia in children and adolescents. Biol Psychiatry 1997;41(suppl):7S-22S.
9. Potenza MN, Holmes JP, Kanes SJ and McDougle CJ, Olanzapine treatment of children, adolescents and adults with pervasive developmental disorders: an open label pilot study. J Clin Psychopharmacol 1999;19:37-44.
10. Bhadrinath BR. Olanzapine in Tourette syndrome (letter). Br J Psychiatry 1998;172:366.
11. La Via MC, Grab N and Kaye WH. Case reports of olanzapine treatment of anorexia nervosa. Int J Eat Disord 2000;27:363-366.
12. Öy B. Çocuklar için depresyon ölçǧi: geçerlik ve güvenirlik çalişmasi. Türk Psikiyatri Dergisi 1991;2:132-136.
13. Savaşir I, Şahin N. Çocuklar için Zeka Ölçeǧi (WISC-R). Ankara: Türk Psikologlar Derneǧi Yayini, 1994.
14. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ. The Yale global tic severity scale: initial testing of a clinician-rated scale of tic severity. J Am Child Adolesc Psychiatry 1988;28:566-573.
15. Zaimoǧlu S, Rodopman Arman A, Sabuncuoglu O. Yale genel tik aǧirliǧini derecelendirme ölçg̃inin güvenirlik çalişmasi. 5. Ulusal Çocuk ve Ergen Psikiyatrisi Kongresinde sunum. Ankara, 1995.
16. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorder, Fourth Edition, (DSMIV), Washington DC, American Psychiatric Press, Inc., 1994.
17. Guy W. CGI Clinical Global Impressions: ECDEU Assesment Manual, revised edition. Rockville, MD: US Department of Health, Education and Welfare 1976;218-222.
18. Chouinard G, Ross-Chouinard A, Annable L. Extrapyramidal symptom rating scale. Can J Neurol Sci 1980;7:233.
19. Turgay A. Turgay Pervasive Developmental Disorders Scale. Copyright and Publication: Integrative Therapy Institute, West Bloomfield, Michigan, 1993.
20. Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999;156:702-709.
21. Ravindran AV, Jones BW, al-Zaid K, Lapierre YD. Effective treatment of mania with olanzapine 2 case reports (letter). J Psychiatry Neurosci 1997;22:345-346.
22. Ketter TA, Winsberg ME, DeGolia SG, Dunai M, Tate DL, Strong CM. Rapid efficacy of olanzapine augmentation in nonpsychotic bipolar mixed states (letter). Clin Psychiatry 1998;59:83-85.
23. Chang KD, Ketter TA. Mood stabilizer augmentation with olanzapin in acutely manic children. J Child Adolesc Psychopharmacol 2000;10:45-49.
24. Jensen VS, Mejhelde A. Anorexia nervosa: treatment with olanzapine. Br J Psychiatry 2000;177:87.
25. Horrigan JP, Bornhill KJ, Courvoisie HE. Olanzapine in PDD (letter). J Am Acad Child Adolesc Psychiatry 1997;36:1166.
26. Hage MK.Olanzapine in Tourette's disorder (letter). J Am Acad Child Adolesc Psychiatry 2000;39:139.
27. Semerci ZB. Olanzapine in Tourette's disorder (letter). J Am Acad Child Adolesc Psychiatry 2000;39:140.
28. Stamenkovic M, Schindler D, Aschauer HN and Kasper S. Effective open-label treatment of Tourette's disorder with olanzapine. Int Clin Psychopharmacol 2000;15:23-28.